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ABSTRACT
Members of the filamentous fungal genus Fusarium are among the agents most frequently causing
keratomycosis in humans. Fusarium keratitis is most common among agricultural workers in
geographical regions with hot, humid, tropical or semi-tropical climates, but can occur more rarely in
countries with temperate climates, such as Hungary. Keratitis is usually treated with a topical antifungal
agent, sometimes in combination with sub-conjunctival injections and ⁄ or antimycotic agents, but
therapeutic keratoplasty may be needed for patients whose corneal infection does not resolve. Early and
accurate diagnosis, coupled with appropriate antifungal therapy, is crucial for improving the chances of
complete recovery.
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Keratomycosis is a suppurative, usually ulcera-
tive corneal disease [1]. Infection is exogenous,
with the organism entering through the corneal
epithelium. The most common filamentous fungi
involved in mycotic keratitis are Fusarium and
Aspergillus spp.
Fusarium spp. are found commonly in soil,
marine or river environments, and on plants
throughout the world. Certain species are plant
pathogens, while others are soil saprophytes [2].
However, in recent years they have been reported
with increasing frequency as aetiological agents in
opportunistic infections [3]. Fusariosis occurs
most frequently as a localised infection of the
cornea, but the incidence of Fusarium spp. among
culture-proven cases of fungal keratitis varies
between different countries (Table 1). Fusarium
spp. were the predominant aetiological agents of
keratomycosis in many surveys [6–8,10,12,13,17,
20–24,26], while Aspergillus spp. [4,11,14–16,18,19]
and Candida spp. [9,25] predominated in other
studies. The species reported most often was
Fusarium solani [13,17,20,23,26,27], and Fusarium
keratitis may occur as a mixed infection with
bacteria, mainly Streptococcus and Staphylococcus
spp. [13,21,27], or herpes simplex virus [27].
The epidemiological pattern of Fusarium kerati-
tis varies from country to country, with less
developed, tropical and sub-tropical countries
being most affected. Climate seems to play an
important role in determining the predominance
of certain species in fungal keratitis. Particular
regions of different continents, e.g., southern
Florida, Ghana and southern India, share similar
climatic conditions, which seem to favour the
predominance of Fusarium spp. [10,12,13,26]. In
contrast, keratitis caused by Fusarium spp. is rare
in European countries with temperate climates:
only four cases have been reported from Paris,
France in 8 years [9], and only a single case has
been diagnosed in Hungary (see below). The
incidence of Fusarium spp. in mycotic keratitis
may also vary with climatic conditions within a
single country, as demonstrated by data from
different parts of China [6–8], Ghana [10] and
India [10–18] (Table 1). Where reported, the pro-
portion of farmers and agricultural workers
among patients with mycotic keratitis in these
studies was relatively high (16–86%). Male
patients were more frequent than females, with
male:female ratios of between 1.4:1 and 3.5:1, with
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the exception of a study from Nepal, where both
sexes were affected equally [19]. The average age
of the patients in the studies ranged from 35.8 to
59 years.
Corneal trauma was the most common predis-
posing factor for keratomycosis, with an incidence
ranging from 31.6% to 89.9%, apart from a study
from Pennsylvania, in which only 8.3% of the
patients reported a recent trauma [25]. The injuries
were caused by various traumatising agents,
including plant material (paddy, tree branch,
thorn, hay, sugar cane, grass, corn stalks, onions,
ground nuts, kernel, palm leaf), animal matter
(cow’s tail, cow dung, insect, cat scratch, hen
peck), dust, soil, mud, stones, glass, metal objects
and fingernails. Other reported predisposing fac-
tors included the use of topical corticosteroids,
previous eye surgery, pre-existing ocular diseases
(e.g., lagophthalmos, chronic dacryocystitis, cor-
neal scaring or ulcer), systemic diseases such as
diabetes mellitus or leprosy, and the wearing of
contact lenses. In a study from Tanzania, a positive
correlation was found with HIV carriage, in that
81.2% of patients with fungal keratitis were HIV-
positive, compared with only 33% of those with
non-fungal keratitis [23].
A possible complication after infection of the
cornea by Fusarium spp. is endophthalmitis,
which may result in the deterioration of visual
acuities, including the loss of light perception. Of
159 cases of Fusarium keratitis in Florida, ten
patients progressed to endophthalmitis, suggest-
ing the importance of an early diagnosis and
suspicion of endophthalmitis in patients with
keratomycosis that does not respond to aggres-
sive topical antifungal treatment [28].
The first sign of fungal keratitis may be the
presence of a coarse granular infiltration of the
corneal epithelium and the anterior stroma [29].
However, this symptom also occurs with bacterial
keratitis; therefore, microbial investigation is
necessary to confirm the pathogen. Direct micro-
scopic examination of stained ocular samples
can help to detect fungi, but identification to
the genus level is generally not considered
possible [1].
Culturing of scrapings or a tissue biopsy from
the infected area can yield the fungus. In this case,
the cultures are used for susceptibility testing.
Fusarium spp. grow rapidly on Sabouraud dex-
trose agar plates, forming colonies that are usu-
ally ‘woolly’, with a white, yellow, pink or purple
colour on the surface. The underside is palered,
violet or brown. Typically, these organisms pro-
duce curved, multicellular macroconidia. How-
ever, negative culture results can be obtained
following previous antifungal therapy, or if there
has been difficulty in obtaining the specimen from
a deep infection. PCR-based tests can also be used
to detect fungi in infected corneas [30].
Table 1. Incidence of Fusarium spp. among culture-proven cases of fungal keratitis (based on retrospective studies)
Geographical location Time period
Total number of
mycotic keratitis cases
Number of cases caused
by Fusarium spp. Reference
Bangladesh 11 months 51 10 (19.6%) [4]
Bangladesh Unknown 63 22 (34.9%) [5]
China, Beijing (north) January 1995 to October 2000 498 321 (64.5%) [6]
China, Zhengzhou (central) January 1975 to June 1997 615 NA (65.0%) [7]
China, Shijiazhuang (north) NA (33.3%)
China, Guangzhou (south) NA (39.2%)
China, Quingdao (north) 4 years 97 63 (64.9%) [8]
France, Paris January 1993 to January 2001 19 4 (21.1%) [9]
Ghana, Accra (south) June 1999 to May 2001 43 27 (62.8%) [10]
Ghana (Ashanti and upper east) June 1999 to May 2001 48 15 (31.3%) [10]
India, Tiruchirapalli (south) June 1999 to May 2001 353 141 (39.9%) [10]
India, Chandigarh (north) 6 years 61 10 (16.4%) [11]
India, Hyderabad (south) January 1991 to December 2000 1360 506 (37.2%) [12]
India, Madurai (south) January 1994 to March 1994 155 73 (47.1%) [13]
India, Madras (south) 1980–1982 68 8 (11.8%) [14]
India, New Delhi (north) 5 years 211 30 (14.2%) [15]
India, Patna (east) 2 years 76 6 (7.9%) [16]
India, Tiruchirapalli (south) July 1985 to November 1985 40 19 (47.5%) [17]
India, Mumbai (west) 1988–1996 367 33 (9.0%) [18]
Nepal 1985–1987 68 8 (11.8%) [19]
Nigeria 1974–1977 42 15 (35.7%) [20]
Paraguay April 1988 to April 1989 26 11 (42.3%) [21]
Singapore January 1991 to December 1995 29 15 (51.7%) [22]
Tanzania October 1994 to October 1995 32 24 (75.0%) [23]
Thailand (central) January 1988 to December 2000 35 12 (34.3%) [24]
USA, Pennsylvania January 1991 to March 1999 24 6 (25.0%) [25]
USA, south Florida January 1982 to January 1992 125 79 (63.2%) [26]
NA, specific data not available.
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Usually, keratitis is treated with a topical
antifungal agent, sometimes in combination with
sub-conjunctival injections of the same drug
and ⁄ or oral antimycotic agents [29]. Natamycin
is the preferred initial agent for the treatment of
filamentous fungal keratitis. Amphotericin B lipid
complex, voriconazole and oral or topical ketoc-
onazole, are also effective in the treatment of
fusarial keratitis [1,28,29]. Therapeutic keratopl-
asty may be needed for patients whose corneal
infection does not resolve during antifungal
therapy [8,27].
In our own experience, a case of keratomycosis
caused by a mixed infection involving Fusarium
verticillioides was diagnosed in a 47-year-old
Hungarian man. In addition to a trauma in his
left eye, another potential predisposing factor was
untreated diabetes. After the injury, the corneal
epithelial lesion developed into a severe visual
impairment, despite local antibiotic (ciprofloxa-
cin) and steroid (prednisolone, dexamethasone)
treatment. After 4 weeks, a dense, mesh-like
structure in the anterior chamber attached to the
posterior surface of the cornea was revealed by
ultrasound biomicroscopy. Local natamycin ther-
apy was started, but the mesh-like structure pro-
gressed, filling almost the entire anterior chamber.
Penetrating keratoplasty was performed as the
only possible treatment. Intra-operative samples
taken from the cornea and the anterior chamber
yielded bacteria (Staphylococcus epidermidis, an
a-haemolytic streptococcus and Propionibacterium
acnes) and a filamentous fungus (F. verticillioides).
Local steroid (prednisolone) and antibiotic (neo-
mycin and tobramycin) treatment, combined with
oral itraconazole therapy, were started post-oper-
atively. The diabetic status improved following
the initiation of insulin therapy. Three months
later, the host and graft cornea were transparent
without inflammatory signs, and the best correc-
ted vision was 0.9.
In conclusion, Fusarium keratitis is rare in
temperate climates, but frequent in agriculture-
based geographical regions with hot, humid,
tropical or sub-tropical climates. Those at highest
risk are young and middle-aged farmers, as they
are more exposed to the possibility of corneal
trauma with infected material. Early and accurate
microbiological diagnosis, coupled with appro-
priate treatment, is crucial for increasing the
chances of complete recovery.
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